Janiri, Luigi
 Distribuzione geografica
Continente #
EU - Europa 14.482
NA - Nord America 11.971
AS - Asia 8.024
SA - Sud America 1.465
AF - Africa 213
OC - Oceania 82
Continente sconosciuto - Info sul continente non disponibili 16
Totale 36.253
Nazione #
US - Stati Uniti d'America 11.609
IT - Italia 5.979
SG - Singapore 3.884
DE - Germania 2.969
CN - Cina 1.835
SE - Svezia 1.218
BR - Brasile 1.168
FR - Francia 1.038
UA - Ucraina 770
VN - Vietnam 678
GB - Regno Unito 594
IE - Irlanda 371
IN - India 321
FI - Finlandia 297
PL - Polonia 271
ID - Indonesia 261
RU - Federazione Russa 231
NL - Olanda 219
CA - Canada 202
HK - Hong Kong 176
JP - Giappone 165
TR - Turchia 128
BD - Bangladesh 113
AR - Argentina 109
MX - Messico 97
CH - Svizzera 96
ES - Italia 81
AU - Australia 70
IQ - Iraq 69
BE - Belgio 64
AT - Austria 47
ZA - Sudafrica 46
CO - Colombia 42
CI - Costa d'Avorio 40
IR - Iran 40
PK - Pakistan 39
EC - Ecuador 36
SA - Arabia Saudita 35
KR - Corea 34
RO - Romania 33
CL - Cile 29
MA - Marocco 26
GR - Grecia 24
VE - Venezuela 24
CZ - Repubblica Ceca 23
IL - Israele 23
LT - Lituania 22
UZ - Uzbekistan 22
AL - Albania 21
PH - Filippine 19
EG - Egitto 18
HU - Ungheria 18
AE - Emirati Arabi Uniti 17
KE - Kenya 17
PE - Perù 17
PY - Paraguay 17
NP - Nepal 16
DZ - Algeria 15
JO - Giordania 15
MY - Malesia 15
AZ - Azerbaigian 14
KZ - Kazakistan 14
TN - Tunisia 14
DO - Repubblica Dominicana 13
UY - Uruguay 13
NZ - Nuova Zelanda 12
PA - Panama 12
LB - Libano 11
NO - Norvegia 11
PT - Portogallo 10
RS - Serbia 10
TH - Thailandia 10
KG - Kirghizistan 9
OM - Oman 9
BO - Bolivia 8
MT - Malta 8
TW - Taiwan 8
A1 - Anonimo 7
BY - Bielorussia 7
CR - Costa Rica 7
DK - Danimarca 7
HR - Croazia 7
JM - Giamaica 7
LV - Lettonia 7
AM - Armenia 6
MN - Mongolia 6
NG - Nigeria 6
TT - Trinidad e Tobago 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BG - Bulgaria 5
BH - Bahrain 5
ET - Etiopia 5
LU - Lussemburgo 5
PS - Palestinian Territory 5
QA - Qatar 5
SN - Senegal 5
GA - Gabon 4
LK - Sri Lanka 4
MD - Moldavia 4
NI - Nicaragua 4
Totale 36.188
Città #
Singapore 2.132
Chandler 1.575
Ashburn 1.294
San Jose 1.120
Milan 709
Rome 612
Jacksonville 413
San Mateo 378
Dublin 362
Beijing 308
New York 308
Wilmington 267
Ho Chi Minh City 232
Jakarta 230
Nanjing 228
Los Angeles 227
Lauterbourg 221
Woodbridge 217
Warsaw 200
Hanoi 164
Ann Arbor 163
Houston 162
Boston 153
Dearborn 151
Frankfurt am Main 147
Hefei 143
Hong Kong 143
Redwood City 143
The Dalles 140
Dallas 139
Nürnberg 133
Moscow 131
Munich 123
Tokyo 123
Seattle 121
Fairfield 114
São Paulo 108
Lawrence 106
Nanchang 100
Bremen 96
Helsinki 96
Marseille 93
Cattolica 91
Naples 90
Princeton 89
Council Bluffs 82
Florence 82
Paris 82
Turin 81
Buffalo 80
Norwalk 72
Bologna 71
Chicago 68
Lancaster 61
Boardman 58
Guangzhou 58
Santa Clara 57
London 55
Bari 54
Genoa 54
Mountain View 54
University Park 51
Falls Church 49
Burlington 47
Catania 47
Hebei 47
Toronto 46
Brussels 45
Hangzhou 45
Orem 44
Palermo 44
Pune 44
Brescia 43
Shanghai 43
Shenyang 43
Verona 43
Cambridge 41
Changsha 41
Abidjan 40
Rio de Janeiro 40
Düsseldorf 38
Fremont 38
Chennai 37
Da Nang 37
Kunming 37
Tianjin 37
Atlanta 36
Kent 36
Montreal 36
St Louis 36
Brooklyn 33
Haiphong 33
Izmir 33
Columbus 32
Mexico City 30
Stockholm 30
Belo Horizonte 27
Jiaxing 27
Phoenix 27
Denver 26
Totale 16.873
Nome #
L efficacia del topiramato a basso dosaggio in pazienti alcolisti in fase di post-disintossicazione 3.061
Manuale di Riabilitazione per i Disturbi dell’Umore 967
Psychometric characteristic of the Italian version of the Temperament and Character Inventory--revised, personality, psychopathology, and attachment styles 651
Quetiapine as add-on treatment for Bipolar I Disorder with comorbid compulsive buying and physical exercise addiction 559
Comorbilità tra Disturbi da Uso di Sostanze e disturbi affettivi 459
Monocytes from depressed patients display an altered pattern of response to endotoxin challenge 418
Craving Typology Questionnaire (CTQ): a scale for alcohol craving in normal controls and alcoholics 407
New perspectives on generalized anxiety disorder 404
Description and validation of a questionnaire for the detection of meteoropathy and meteorosensitivity: the METEO-Q 355
Bipolar disorder and gambling disorder comorbidity: current evidence and implications for pharmacological treatment 318
Childhood trauma, resilience and depression 300
PSYCHOMETRIC TESTS AND RISK FACTORS FOR SCREENING OF MOOD DISORDERS IN PREGNANCY AND POST-PARTUM: A PRELIMINARY STUDY. 289
Behavioural addictions in bipolar disorder patients: Role of impulsivity and personality dimensions 278
Alterazioni delle risposte immuno-infiammatorie nei pazienti affetti da disturbo depressivo maggiore (Immune-inflammatory response changes in patients with major depressive disorder) 268
Alcol e lavoro. Documento di consenso del gruppo LaRA 267
Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial. 264
Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial 262
Programma di trattamento integrato in regime di day hospital per pazienti depressi “difficili” da trattare. 251
Bipolar Disorder Questionnaire for the Assessment of Learning: a New Instrument for Studying Information Acquisition in Psychoeducational programs. 242
Cognitive markers of psychotic unipolar depression: A meta-analytic study 237
Neuroendocrinologia dei disturbi dell umore 230
Augmentation of drug treatment with bright light therapy in patients with difficult-to-treat depression: acute and long term observation 220
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up 214
[Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study] 211
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up. 211
Dopamine transporter availability in gambling disorder: preliminary 123I-FP-CIT SPECT results 204
Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial 201
Striatal dopamine transporter (DAT) availability and affective symptoms in movement disorders: a 123I-FP-CIT SPECT study. 200
Pharmacological Treatment of Internet Addiction 200
Further evidence supporting the association between 5HTR2C gene and bipolar disorder 199
Role of Substance Abuse Comorbidity and Personality on the Outcome of Depression in Bipolar Disorder: Harm Avoidance Influences Medium-Term Treatment Outcome. 198
Association of polymorphism (Val66Met) of brain-derived neurotrophic factor with suicide attempts in depressed patients 196
Problematic mobile phone use in adolescence: A cross-sectional study 195
Depression, inflammation and coronary heart disease: prognostical value of C-reactive protein and depressive symptoms. 192
Temperament and attachment in alcohol addicted patients of type 1 and 2 192
[Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study]. 189
Clinical insights by the presence of bipolar disorder in pseudohypoparathyroidism type 1A 189
Il trattamento integrato dei Disturbi dell’Umore: "Il ruolo dei farmaci" 187
A Role for Pharmacotherapy in the Treatment of “Internet Addiction” 185
Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a (123)I-FP-CIT SPECT study 185
The importance of cognitive assessment in the management of psychiatric disorders 185
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up 182
Plasma magnesium levels and treatment outcome in depressed patients 181
Adult attention-deficit/hyperactivity disorder in major depressed and bipolar subjects: role of personality traits and clinical implications 178
[Separation anxiety disorder: evidence of literature and clinical implications] 178
Affective temperaments and psychopathological dimensions of personality in bipolar and cyclothymic patients 177
Treatment of prurigo nodularis with pregabalin. 176
Low-dose topiramate in alcohol dependence: a single-blind, placebo-controlled study 174
Factors associated with the course of symptoms in bipolar disorder during a 1-year follow-up: depression vs. sub-threshold mixed state 173
Reduced hedonic capacity in euthymic bipolar subjects: A trait-like feature? 172
Alcohol protracted withdrawal syndrome: the role of anhedonia 169
Topiramate in Alcohol Use Disorders: Review and Update. 167
An observational study evaluating comorbidity between bipolar disorder and personality disorders 165
Polysomnographic Findings in a Cohort of Chronic Insomnia Patients with Benzodiazepines Abuse 165
Traumatic life experiences and major depression: an overview 165
Affective dependence and aggression: an exploratory study 164
Serum 25-hydroxyvitamin D levels and psychological distress symptoms in patients with affective disorders during the COVID-19 pandemic 164
Plasma magnesium levels and treatment outcome in depressed patients 163
Role of substance abuse comorbidity and personality on the outcome of depression in bipolar disorder: harm avoidance influences medium-term treatment outcome 162
Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study 162
Changes of Dopamine Transporter Availability in Depressed Patients with and without Anhedonia: A 123I-N-ω-Fluoropropyl-Carbomethoxy-3β-(4-Iodophenyl)tropane SPECT Study 162
Clinical Presentation 161
Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome. 160
Behavioural addictions in adolescents and young adults: results from a prevalence study. 159
Cognitive markers of psychotic unipolar depression: A meta-analytic study 159
Pregabalin augmentation in treatment-resistant obsessive-compulsive disorder: a 16-week case series 157
PRELIMINARY ANALYSIS OF GENES INVOLVED IN INFLAMMATORY, OXIDATIVE PROCESSES AND CA2+SIGNALING IN BIPOLAR DISORDER AND COMORBIDITY FOR SUBSTANCE USE DISORDER 155
Organizzazione di un gruppo di Auto-Mutuo-Aiuto “Facilitato” per pazienti depressi. 155
Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up 155
Gender Differences and Psychopathological Features Associated With Addictive Behaviors in Adolescents. 155
Anomalous self-experience, body image disturbance, and eating disorder symptomatology in first-onset anorexia nervosa 155
Organizzazione di un gruppo di psicoeducazione per pazienti bipolari. 154
Acetyl-L-carnitine for alcohol craving and relapse prevention in anhedonic alcoholics: a randomized, double-blind, placebo-controlled pilot trial. 152
Il trattamento della schizofrenia 152
Affective temperament and attachment in adulthood in patients with Bipolar Disorder and Cyclothymia 152
Depression Symptoms and Clinical Subtypes in Parkinson's Disease Patients: a I-123-FP-CIT SPECT Study 151
Somatic symptoms and high-sensitive C-reactive protein in major depression 150
Co-occurrence of alcohol use disorder and behavioral addictions: relevance of impulsivity and craving 150
A Mixed Program of Psychoeducational and Psychological Rehabilitation for Patients With Bipolar Disorder in a Day Hospital Setting. 150
Augmentation of light therapy in difficult-to-treat depressed patients: an open-label trial in both unipolar and bipolar patients 149
Oxcarbazepine in bipolar disorder: a critical review of the literature 148
Allostasis as a conceptual framework linking bipolar disorder and addiction 148
Serotoninergic and dopaminergic genes in bipolar disorder and response to treatments in bipolar depression. Investigation on a well-characterized naturalistic sample 147
L’interazione gene-ambiente nell’alcolismo 147
Clinical correlates of difficult-to-treat depression: Exploring an integrated day-care model of treatment 146
Further evidence supporting the influence of brain-derived neurotrophic factor on the outcome of bipolar depression: independent effect of brain-derived neurotrophic factor and harm avoidance 145
Treatment of prurigo nodularis with pregabalin 145
Agomelatine increases BDNF serum levels in depressed patients in correlation with the improvement of depressive symptoms 145
Pharmacological and Psychosocial Treatment of Adults With Gambling Disorder: A Meta-Review 145
Mental health during and after the COVID-19 emergency in Italy 144
Mood, hormones and quality of life. 143
Predictive value of magnesium levels in depressed patients. 143
Acetyl-l-Carnitine in the treatment of anhedonia, melancholic and negative symptoms in alcohol dependent subjects 143
Targeting the glutamatergic system to treat pathological gambling: current evidence and future perspectives 143
Duloxetine for premenstrual dysphoric disorder: a pilot study 142
Pharmacological treatments in alcohol use disorders: state of art and new perspectives 142
Behavioural addictions in adolescents and young adults: results from a prevalence study 141
The assessment of post-detoxification anhedonia: influence of clinical and psychosocial variables 140
Gabapentin as add-on treatment for somatoform disorder: a case report 139
Acetyl-L-Carnitine in the management of pain during methadone withdrawal syndrome 139
Totale 23.645
Categoria #
all - tutte 123.865
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.865


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021339 0 0 0 0 0 0 0 0 0 0 271 68
2021/20222.245 193 184 60 109 114 103 108 365 140 154 334 381
2022/20235.314 595 614 372 752 365 558 334 496 607 152 267 202
2023/20243.288 225 667 165 243 196 442 171 157 138 189 355 340
2024/20255.246 260 255 409 277 496 223 191 328 760 487 816 744
2025/202610.827 1.442 359 660 1.135 2.147 624 2.014 690 778 910 68 0
Totale 36.612